View Financial HealthGivaudan 配当と自社株買い配当金 基準チェック /56Givaudan配当を支払う会社であり、現在の利回りは2.63%で、収益によって十分にカバーされています。主要情報2.6%配当利回り0.1%バイバック利回り総株主利回り2.7%将来の配当利回り2.9%配当成長3.0%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向62%最近の配当と自社株買いの更新お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.すべての更新を表示Recent updatesお知らせ • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027お知らせ • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.お知らせ • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.お知らせ • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026お知らせ • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.お知らせ • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026お知らせ • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.お知らせ • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025お知らせ • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025お知らせ • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.お知らせ • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025お知らせ • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.お知らせ • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024お知らせ • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.お知らせ • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024お知らせ • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023お知らせ • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023お知らせ • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.決済の安定と成長配当データの取得安定した配当: GVDB.Fの1株当たり配当金は過去10年間安定しています。増加する配当: GVDB.Fの配当金は過去10年間にわたって増加しています。配当利回り対市場Givaudan 配当利回り対市場GVDB.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (GVDB.F)2.6%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Chemicals)1.7%アナリスト予想 (GVDB.F) (最長3年)2.9%注目すべき配当: GVDB.Fの配当金 ( 2.63% ) はUS市場の配当金支払者の下位 25% ( 1.39% ) よりも高くなっています。高配当: GVDB.Fの配当金 ( 2.63% ) はUS市場の配当金支払者の上位 25% ( 4.21% ) と比較すると低いです。株主への利益配当収益カバレッジ: GVDB.Fの配当金は、合理的な 配当性向 ( 62% ) により、利益によって賄われています。株主配当金キャッシュフローカバレッジ: GVDB.Fは合理的な 現金配当性向 ( 54.9% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/06 01:49終値2026/05/04 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Givaudan SA 18 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。37 アナリスト機関Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchJames KnightBarclays34 その他のアナリストを表示
お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.
お知らせ • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027
お知らせ • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.
お知らせ • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.
お知らせ • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.
お知らせ • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026
お知らせ • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.
お知らせ • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026
お知らせ • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.
お知らせ • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025
お知らせ • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025
お知らせ • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.
お知らせ • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025
お知らせ • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.
お知らせ • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024
お知らせ • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.
お知らせ • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024
お知らせ • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023
お知らせ • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023
お知らせ • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.